These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 30323638

  • 1. Obesity management in Prader-Willi syndrome: current perspectives.
    Crinò A, Fintini D, Bocchini S, Grugni G.
    Diabetes Metab Syndr Obes; 2018; 11():579-593. PubMed ID: 30323638
    [Abstract] [Full Text] [Related]

  • 2.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Driscoll DJ, Miller JL, Cassidy SB.
    ; 1993. PubMed ID: 20301505
    [Abstract] [Full Text] [Related]

  • 3. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
    Gunay-Aygun M, Schwartz S, Heeger S, O'Riordan MA, Cassidy SB.
    Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
    [Abstract] [Full Text] [Related]

  • 4. Prader-Willi syndrome: an update on obesity and endocrine problems.
    Kim SJ, Cho SY, Jin DK.
    Ann Pediatr Endocrinol Metab; 2021 Dec; 26(4):227-236. PubMed ID: 34991300
    [Abstract] [Full Text] [Related]

  • 5. Medication Trials for Hyperphagia and Food-Related Behaviors in Prader-Willi Syndrome.
    Miller JL, Strong TV, Heinemann J.
    Diseases; 2015 Jun 03; 3(2):78-85. PubMed ID: 28943610
    [Abstract] [Full Text] [Related]

  • 6. Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.
    Muscogiuri G, Barrea L, Faggiano F, Maiorino MI, Parrillo M, Pugliese G, Ruggeri RM, Scarano E, Savastano S, Colao A, RESTARE.
    J Endocrinol Invest; 2021 Oct 03; 44(10):2057-2070. PubMed ID: 33891302
    [Abstract] [Full Text] [Related]

  • 7. Prader- Willi syndrome: An uptodate on endocrine and metabolic complications.
    Muscogiuri G, Formoso G, Pugliese G, Ruggeri RM, Scarano E, Colao A, RESTARE.
    Rev Endocr Metab Disord; 2019 Jun 03; 20(2):239-250. PubMed ID: 31065942
    [Abstract] [Full Text] [Related]

  • 8. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
    Angulo MA, Butler MG, Cataletto ME.
    J Endocrinol Invest; 2015 Dec 03; 38(12):1249-63. PubMed ID: 26062517
    [Abstract] [Full Text] [Related]

  • 9. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY, Myers S, Carrel A, Allen D.
    Pediatrics; 2002 Feb 03; 109(2):E35. PubMed ID: 11826245
    [Abstract] [Full Text] [Related]

  • 10. Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments.
    Griggs JL, Sinnayah P, Mathai ML.
    Neurosci Biobehav Rev; 2015 Dec 03; 59():155-72. PubMed ID: 26475993
    [Abstract] [Full Text] [Related]

  • 11. Approach to the Patient With Prader-Willi Syndrome.
    Höybye C, Tauber M.
    J Clin Endocrinol Metab; 2022 May 17; 107(6):1698-1705. PubMed ID: 35150573
    [Abstract] [Full Text] [Related]

  • 12. Endocrine manifestations and management of Prader-Willi syndrome.
    Emerick JE, Vogt KS.
    Int J Pediatr Endocrinol; 2013 Aug 21; 2013(1):14. PubMed ID: 23962041
    [Abstract] [Full Text] [Related]

  • 13. Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.
    Correa-da-Silva F, Fliers E, Swaab DF, Yi CX.
    J Neuroendocrinol; 2021 Jul 21; 33(7):e12994. PubMed ID: 34156126
    [Abstract] [Full Text] [Related]

  • 14. Systematic review of the clinical and genetic aspects of Prader-Willi syndrome.
    Jin DK.
    Korean J Pediatr; 2011 Feb 21; 54(2):55-63. PubMed ID: 21503198
    [Abstract] [Full Text] [Related]

  • 15. Dietary Management for Adolescents with Prader-Willi Syndrome.
    Miller JL, Tan M.
    Adolesc Health Med Ther; 2020 Feb 21; 11():113-118. PubMed ID: 32922110
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of obesity in Prader-Willi syndrome.
    Khan MJ, Gerasimidis K, Edwards CA, Shaikh MG.
    Pediatr Obes; 2018 Jan 21; 13(1):3-13. PubMed ID: 27863129
    [Abstract] [Full Text] [Related]

  • 17. Proteins and proteases of Prader-Willi syndrome: a comprehensive review and perspectives.
    Basak S, Basak A.
    Biosci Rep; 2022 Jun 30; 42(6):. PubMed ID: 35621394
    [Abstract] [Full Text] [Related]

  • 18. Advances in genetic mechanisms of hypothalamic dysfunction in Prader-Willi syndrome.
    Wang XY, Sun R, Gao YQ.
    Yi Chuan; 2022 Oct 20; 44(10):899-912. PubMed ID: 36384726
    [Abstract] [Full Text] [Related]

  • 19. Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome.
    McCarthy JM, McCann-Crosby BM, Rech ME, Yin J, Chen CA, Ali MA, Nguyen HN, Miller JL, Schaaf CP.
    J Med Genet; 2018 May 20; 55(5):307-315. PubMed ID: 29496979
    [Abstract] [Full Text] [Related]

  • 20. Relationship of thyroid function with genetic subtypes and treatment with growth hormone in Prader-Willi syndrome.
    Schmok T, Surampalli A, Khare M, Zandihaghighi S, Baghbaninogourani R, Patolia B, Gold JA, Naidu A, Cassidy SB, Kimonis VE.
    Am J Med Genet A; 2024 Oct 20; 194(10):e63724. PubMed ID: 38837660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.